Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer--testing, incidence, surgery and mortality.

Laurie Gibbons1, Chris Waters

  • 1Health Statistics Division, Statistics Canada, Ottawa, Ontario, K1A 0T6. laurie.gibbons@statcan.ca

Health Reports
|June 21, 2003
PubMed
Summary

In 2000/01, 43% of Canadian men over 40 had a prostate-specific antigen (PSA) test. Prostate cancer incidence has fallen since the 1990s, while mortality decreased in older men.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Tool to Assess Risk of Type 2 Diabetes in Canadian Adults.

Canadian journal of diabetes·2020
Same author

Erratum for Chodur et al., "The Proline Variant of the W[F/L/M][T/S]R Cyclic Di-GMP Binding Motif Suppresses Dependence on Signal Association for Regulator Function".

Journal of bacteriology·2018
Same author

A brief visit from a red and extremely elongated interstellar asteroid.

Nature·2017
Same author

The Proline Variant of the W[F/L/M][T/S]R Cyclic Di-GMP Binding Motif Suppresses Dependence on Signal Association for Regulator Function.

Journal of bacteriology·2017
Same author

Assessing the burden of hospitalized and community-care heart failure in Canada.

The Canadian journal of cardiology·2014
Same author

Comparing life expectancy and health-adjusted life expectancy by body mass index category in adult Canadians: a descriptive study.

Population health metrics·2013

Area of Science:

  • Urology
  • Public Health
  • Cancer Epidemiology

Background:

  • Prostate cancer screening using the prostate-specific antigen (PSA) test is a key public health topic.
  • Understanding trends in PSA testing, incidence, surgery, and mortality is crucial for clinical practice and health policy.
  • Recent data on these trends in Canada are needed to inform current strategies.

Purpose of the Study:

  • To examine recent prostate-specific antigen (PSA) test utilization among Canadian men.
  • To present trends in prostate cancer incidence, surgical interventions, and mortality rates.
  • To identify significant changes and provincial variations in these metrics.

Main Methods:

  • Utilized data from Canadian health surveys, cancer registries, and mortality databases (2000/01).
  • Calculated age-standardized rates for prostate cancer incidence, surgery, and mortality.
  • Employed joinpoint analysis for trend detection and ANOVA for provincial comparisons.

Main Results:

  • 43% of Canadian men aged 40+ reported PSA testing in 2000/01.
  • Prostate cancer incidence peaked in the early 1990s and has since declined.
  • Mortality rates decreased for men 60+, but remained stable for younger men; provincial differences were not significant.

Conclusions:

  • PSA testing is prevalent in Canadian men over 40.
  • Prostate cancer incidence and mortality trends show a decline, particularly in older age groups.
  • While PSA testing rates vary provincially, overall incidence and mortality rates are comparable across Canada.

Related Experiment Videos